Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

COPD Topic Center

News
02/09/2024
A new study compares the efficacy of salbutamol administration via a nebulizer vs a metered-dose inhaler with a spacer for bronchodilator responsiveness testing.
A new study compares the efficacy of salbutamol administration via a nebulizer vs a metered-dose inhaler with a spacer for bronchodilator responsiveness testing.
A new study compares the...
02/09/2024
First Report Managed Care
News
10/05/2023
Considering an emphysema frequency of 20% to 30%, a full implementation of CT-based LCS in which 75% were asymptomatic screening participants, as many as 2.6 to 3 million would learn that they have emphysema detected.
Considering an emphysema frequency of 20% to 30%, a full implementation of CT-based LCS in which 75% were asymptomatic screening participants, as many as 2.6 to 3 million would learn that they have emphysema detected.
Considering an emphysema...
10/05/2023
First Report Managed Care
Newsfeed
12/14/2018
Antibiotics for acute exacerbations of COPD offer strong benefit for patients in the intensive care unit but just small effects for other inpatients as well as outpatients, according to a recent systematic review. 
Antibiotics for acute exacerbations of COPD offer strong benefit for patients in the intensive care unit but just small effects for other inpatients as well as outpatients, according to a recent systematic review. 
Antibiotics for acute...
12/14/2018
First Report Managed Care
Newsfeed
12/11/2018
A population-based disease management program significantly reduced admissions for patients with COPD and diabetes but failed to significantly cut costs for higher-risk patients as a whole, according to results from a recent study.
A population-based disease management program significantly reduced admissions for patients with COPD and diabetes but failed to significantly cut costs for higher-risk patients as a whole, according to results from a recent study.
A population-based disease...
12/11/2018
First Report Managed Care
Newsfeed
12/04/2018
Machine learning techniques applied to telemonitoring datasets are better than existing algorithms at predicting COPD exacerbations requiring hospitalization and decisions to start corticosteroids, researchers found.
Machine learning techniques applied to telemonitoring datasets are better than existing algorithms at predicting COPD exacerbations requiring hospitalization and decisions to start corticosteroids, researchers found.
Machine learning techniques...
12/04/2018
First Report Managed Care
News
10/26/2018
A new study published by the American Thoracic Society investigated the long-term effects of benzodiazepine use among veterans with COPD and PTSD.
A new study published by the American Thoracic Society investigated the long-term effects of benzodiazepine use among veterans with COPD and PTSD.
A new study published by the...
10/26/2018
First Report Managed Care
News
10/17/2018
Patients with COPD and chronic respiratory failure who use noninvasive ventilation at home had lower costs and hospitalization rates compared with those who used a bilevel positive airway pressure device or no home ventilation support,...
Patients with COPD and chronic respiratory failure who use noninvasive ventilation at home had lower costs and hospitalization rates compared with those who used a bilevel positive airway pressure device or no home ventilation support,...
Patients with COPD and chronic...
10/17/2018
First Report Managed Care
News
10/16/2018
A COPD care discharge bundle lowered 30-, 60-, and 90-day readmission rates among patients hospitalized for acute COPD exacerbations, researchers found. 
A COPD care discharge bundle lowered 30-, 60-, and 90-day readmission rates among patients hospitalized for acute COPD exacerbations, researchers found. 
A COPD care discharge...
10/16/2018
First Report Managed Care
News
10/11/2018
According to a researchers, albuminuria, a common biomarker of microvascular damage in kidney disease, is associated with greater lung function decline, incident COPD, and incident COPD-related events.
According to a researchers, albuminuria, a common biomarker of microvascular damage in kidney disease, is associated with greater lung function decline, incident COPD, and incident COPD-related events.
According to a researchers,...
10/11/2018
First Report Managed Care
News
10/04/2018
Researchers have concluded that the mechanisms underlying the seasonality of COPD exacerbation rates are multifactorial and require research that considers the issue in its entirety. 
Researchers have concluded that the mechanisms underlying the seasonality of COPD exacerbation rates are multifactorial and require research that considers the issue in its entirety. 
Researchers have concluded that...
10/04/2018
First Report Managed Care
News
09/28/2018
Patients with COPD showed significant gains in bronchodilation and symptoms after using a first-in-class dual PDE3/4 inhibitor, according to study recent results. 
Patients with COPD showed significant gains in bronchodilation and symptoms after using a first-in-class dual PDE3/4 inhibitor, according to study recent results. 
Patients with COPD showed...
09/28/2018
First Report Managed Care

Newsfeed

News
02/09/2024
A new study compares the efficacy of salbutamol administration via a nebulizer vs a metered-dose inhaler with a spacer for bronchodilator responsiveness testing.
A new study compares the efficacy of salbutamol administration via a nebulizer vs a metered-dose inhaler with a spacer for bronchodilator responsiveness testing.
A new study compares the...
02/09/2024
First Report Managed Care
News
10/05/2023
Considering an emphysema frequency of 20% to 30%, a full implementation of CT-based LCS in which 75% were asymptomatic screening participants, as many as 2.6 to 3 million would learn that they have emphysema detected.
Considering an emphysema frequency of 20% to 30%, a full implementation of CT-based LCS in which 75% were asymptomatic screening participants, as many as 2.6 to 3 million would learn that they have emphysema detected.
Considering an emphysema...
10/05/2023
First Report Managed Care
News
10/26/2018
A new study published by the American Thoracic Society investigated the long-term effects of benzodiazepine use among veterans with COPD and PTSD.
A new study published by the American Thoracic Society investigated the long-term effects of benzodiazepine use among veterans with COPD and PTSD.
A new study published by the...
10/26/2018
First Report Managed Care
News
10/17/2018
Patients with COPD and chronic respiratory failure who use noninvasive ventilation at home had lower costs and hospitalization rates compared with those who used a bilevel positive airway pressure device or no home ventilation support,...
Patients with COPD and chronic respiratory failure who use noninvasive ventilation at home had lower costs and hospitalization rates compared with those who used a bilevel positive airway pressure device or no home ventilation support,...
Patients with COPD and chronic...
10/17/2018
First Report Managed Care
News
10/16/2018
A COPD care discharge bundle lowered 30-, 60-, and 90-day readmission rates among patients hospitalized for acute COPD exacerbations, researchers found. 
A COPD care discharge bundle lowered 30-, 60-, and 90-day readmission rates among patients hospitalized for acute COPD exacerbations, researchers found. 
A COPD care discharge...
10/16/2018
First Report Managed Care
News
10/11/2018
According to a researchers, albuminuria, a common biomarker of microvascular damage in kidney disease, is associated with greater lung function decline, incident COPD, and incident COPD-related events.
According to a researchers, albuminuria, a common biomarker of microvascular damage in kidney disease, is associated with greater lung function decline, incident COPD, and incident COPD-related events.
According to a researchers,...
10/11/2018
First Report Managed Care
News
10/04/2018
Researchers have concluded that the mechanisms underlying the seasonality of COPD exacerbation rates are multifactorial and require research that considers the issue in its entirety. 
Researchers have concluded that the mechanisms underlying the seasonality of COPD exacerbation rates are multifactorial and require research that considers the issue in its entirety. 
Researchers have concluded that...
10/04/2018
First Report Managed Care
News
09/28/2018
Patients with COPD showed significant gains in bronchodilation and symptoms after using a first-in-class dual PDE3/4 inhibitor, according to study recent results. 
Patients with COPD showed significant gains in bronchodilation and symptoms after using a first-in-class dual PDE3/4 inhibitor, according to study recent results. 
Patients with COPD showed...
09/28/2018
First Report Managed Care
News
09/28/2018
According to a recent study published online in CHEST, in people who smoked heroin and accessed screening services at community drug centers, about half had COPD or asthma-COPD overlap.
According to a recent study published online in CHEST, in people who smoked heroin and accessed screening services at community drug centers, about half had COPD or asthma-COPD overlap.
According to a recent study...
09/28/2018
First Report Managed Care
News
09/25/2018
Based on recent critiques of the current GOLD guidelines, a group of pulmonary clinicians and researchers from the Mayo Clinic have recommended several changes to the next major guideline update.
Based on recent critiques of the current GOLD guidelines, a group of pulmonary clinicians and researchers from the Mayo Clinic have recommended several changes to the next major guideline update.
Based on recent critiques of the...
09/25/2018
First Report Managed Care
News
11/20/2024
The DIAS3 score, developed and validated using data from over 2200 patients, is a simple clinical tool that predicts the risk of post-CVT epilepsy within 1 and 3 years, showing promise for personalized treatment and decision-making.
The DIAS3 score, developed and validated using data from over 2200 patients, is a simple clinical tool that predicts the risk of post-CVT epilepsy within 1 and 3 years, showing promise for personalized treatment and decision-making.
The DIAS3 score, developed and...
11/20/2024
First Report Managed Care
News
11/11/2024
A new study published in Neurology aimed to differentiate age-related brain changes from multiple sclerosis (MS)-specific neurodegeneration using MRI.
A new study published in Neurology aimed to differentiate age-related brain changes from multiple sclerosis (MS)-specific neurodegeneration using MRI.
A new study published in...
11/11/2024
First Report Managed Care
News
11/11/2024
The risks of asthma and asthma-like adverse events appear to be higher with selective β1-blockers than with nonselective blockers and α- and β-blockers.
The risks of asthma and asthma-like adverse events appear to be higher with selective β1-blockers than with nonselective blockers and α- and β-blockers.
The risks of asthma and...
11/11/2024
First Report Managed Care
News
11/08/2024
RNA interference (RNAi)-based treatments for hereditary transthyretin amyloidosis (ATTR) have shown remarkable promise, offering new hope for patients with this rare but devastating genetic disorder.
RNA interference (RNAi)-based treatments for hereditary transthyretin amyloidosis (ATTR) have shown remarkable promise, offering new hope for patients with this rare but devastating genetic disorder.
RNA interference (RNAi)-based...
11/08/2024
First Report Managed Care
News
11/08/2024
A groundbreaking gene therapy for hemophilia B has shown remarkable success in reducing bleeding episodes and improving the quality of life for adult patients, according to a recent international phase III clinical trial.
A groundbreaking gene therapy for hemophilia B has shown remarkable success in reducing bleeding episodes and improving the quality of life for adult patients, according to a recent international phase III clinical trial.
A groundbreaking gene therapy...
11/08/2024
First Report Managed Care
News
11/07/2024
Real-world data shows selexipag effectively improves functional class and risk category outcomes in patients with pulmonary arterial hypertension, regardless of maintenance dose.
Real-world data shows selexipag effectively improves functional class and risk category outcomes in patients with pulmonary arterial hypertension, regardless of maintenance dose.
Real-world data shows selexipag...
11/07/2024
First Report Managed Care
News
11/06/2024
A study published in Annals of Clinical and Translational Neurology aimed to predict 1-year seizure freedom for patients undergoing stereotactic laser amygdalohippocampotomy (SLAH) for mesial temporal lobe epilepsy (MTLE) using a set of...
A study published in Annals of Clinical and Translational Neurology aimed to predict 1-year seizure freedom for patients undergoing stereotactic laser amygdalohippocampotomy (SLAH) for mesial temporal lobe epilepsy (MTLE) using a set of...
A study published in Annals of...
11/06/2024
First Report Managed Care
News
11/05/2024
A meta-analysis of 43 studies suggests that neoadjuvant chemoimmunotherapy may benefit patients with resectable NSCLC and low tumor PD-L1 levels for event-free survival, showing superior outcomes compared to neoadjuvant chemotherapy.
A meta-analysis of 43 studies suggests that neoadjuvant chemoimmunotherapy may benefit patients with resectable NSCLC and low tumor PD-L1 levels for event-free survival, showing superior outcomes compared to neoadjuvant chemotherapy.
A meta-analysis of 43 studies...
11/05/2024
First Report Managed Care
News
11/01/2024
Novartis received accelerated approval by the US Food and Drug Administration (FDA) for asciminib, a medication for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+CML-CP).
Novartis received accelerated approval by the US Food and Drug Administration (FDA) for asciminib, a medication for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+CML-CP).
Novartis received accelerated...
11/01/2024
First Report Managed Care
News
10/30/2024
Ten hospitals sued the US Department of Health and Human Services (HHS), claiming that they were underpaid Medicare reimbursements for serving low-income patients.
Ten hospitals sued the US Department of Health and Human Services (HHS), claiming that they were underpaid Medicare reimbursements for serving low-income patients.
Ten hospitals sued the US...
10/30/2024
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement